These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2532752)

  • 21. Evaluating dementia using PET: how do we put into clinical perspective what we know to date?
    Silverman DH; Phelps ME
    J Nucl Med; 2000 Nov; 41(11):1929-32. PubMed ID: 11079506
    [No Abstract]   [Full Text] [Related]  

  • 22. Regional cerebral glucose metabolism differs in adult and rigid juvenile forms of Huntington disease.
    Matthews PM; Evans AC; Andermann F; Hakim AM
    Pediatr Neurol; 1989; 5(6):353-6. PubMed ID: 2532511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnosis of Alzheimer-type dementia. A preliminary comparison of positron emission tomography and proton magnetic resonance.
    Friedland RP; Budinger TF; Brant-Zawadzki M; Jagust WJ
    JAMA; 1984 Nov; 252(19):2750-2. PubMed ID: 6333523
    [No Abstract]   [Full Text] [Related]  

  • 24. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
    Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J
    Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography: human brain function and biochemistry.
    Phelps ME; Mazziotta JC
    Science; 1985 May; 228(4701):799-809. PubMed ID: 2860723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional cerebral glucose utilization in chronic organic mental disorders associated with alcoholism.
    Martin PR; Rio D; Adinoff B; Johnson JL; Bisserbe JC; Rawlings RR; Rohrbaugh JW; Stapleton JM; Eckardt MJ
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):159-67. PubMed ID: 1627977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's dementia.
    Chase TN; Tamminga CA
    Am J Psychiatry; 1995 Aug; 152(8):1110. PubMed ID: 7625456
    [No Abstract]   [Full Text] [Related]  

  • 28. Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
    Martin WR; Stoessl AJ; Adam MJ; Ammann W; Bergstrom M; Harrop R; Laihinen A; Rogers JG; Ruth TJ; Sayre CI
    Adv Neurol; 1987; 45():95-8. PubMed ID: 3103398
    [No Abstract]   [Full Text] [Related]  

  • 29. Positron emission tomography in partial epilepsy and its relation to clinical and EEG findings.
    Hosokawa S; Kato M; Goto I; Ayabe Z; Kuwabara Y; Ichiya Y
    Jpn J Psychiatry Neurol; 1988 Sep; 42(3):616-7. PubMed ID: 3149381
    [No Abstract]   [Full Text] [Related]  

  • 30. Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia.
    Jagust WJ; Friedland RP; Budinger TF
    J Neurol Neurosurg Psychiatry; 1985 Nov; 48(11):1091-6. PubMed ID: 3878390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Functional significance of calcinosis of the basal ganglia via positron emission tomography].
    Staffen W; Karbe H; Rudolf J; Herholz K; Diederich N; Heiss WD
    Fortschr Neurol Psychiatr; 1994 Apr; 62(4):119-24. PubMed ID: 8206464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical correlates of PET- and SPECT-identified defects in dementia.
    Mayberg HS
    J Clin Psychiatry; 1994 Nov; 55 Suppl():12-21. PubMed ID: 7989290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of PET in dementia disorders.
    Nordberg A
    Acta Neurol Scand Suppl; 1996; 168():71-6. PubMed ID: 8997424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomographic (PET) studies in dementia.
    Goto I; Taniwaki T; Hosokawa S; Otsuka M; Ichiya Y; Ichimiya A
    J Neurol Sci; 1993 Jan; 114(1):1-6. PubMed ID: 8433091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clarification of a fractional uptake concept.
    Thie JA
    J Nucl Med; 1995 Apr; 36(4):711-2. PubMed ID: 7699475
    [No Abstract]   [Full Text] [Related]  

  • 36. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
    Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
    Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography in the early diagnosis of Huntington's disease.
    Hayden MR; Martin WR; Stoessl AJ; Clark C; Hollenberg S; Adam MJ; Ammann W; Harrop R; Rogers J; Ruth T
    Neurology; 1986 Jul; 36(7):888-94. PubMed ID: 2940474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of drawing regions of interest for positron emission tomographic data.
    Small GW; Stern CE; Mandelkern MA; Fairbanks LA; Min CA; Guze BH
    Psychiatry Res; 1992 Nov; 45(3):177-85. PubMed ID: 1484909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
    Koss E; Friedland RP; Ober BA; Jagust WJ
    Am J Psychiatry; 1985 May; 142(5):638-40. PubMed ID: 3872604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [PET imaging of dementia].
    Yokoi F; Ando K
    Nihon Rinsho; 1985 Jul; 43(7):1433-7. PubMed ID: 2932569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.